What is Jude?
Jude operates as a specialized provider of bladder health solutions, addressing a significant gap in the digital health market. Headquartered in London, the company focuses on delivering accessible, data-driven interventions for individuals managing bladder-related conditions. By integrating clinical expertise with user-centric technology, Jude aims to destigmatize and improve the management of chronic health issues that impact millions globally. Their market position is defined by a commitment to evidence-based care, positioning them as a key player in the burgeoning femtech and general healthtech sectors.
How much funding has Jude raised?
Jude has raised a total of $6.8M across 2 funding rounds:
Other Financing Round
$2.6M
Angel/Seed
$4.2M
Other Financing Round (2022): $2.6M with participation from Samos VC, Access VC, and David Rowan
Angel/Seed (2023): $4.2M led by Joyance Partners and Eka Ventures
Key Investors in Jude
Joyance Partners
Joyance Partners is a venture capital firm that invests in companies leveraging science and technology to enhance quality of life, focusing on health and consumer sectors from pre-seed to Series A.
Eka Ventures
Eka Ventures is a venture capital firm dedicated to supporting founders who are creating positive system change through technology, with a focus on sustainable and healthy economic solutions.
Samos VC
Samos VC is an investment firm that provides strategic backing to early-stage companies, focusing on high-growth potential ventures within the European technology ecosystem.
What's next for Jude?
With the recent infusion of capital, Jude is expected to prioritize the scaling of its digital infrastructure and the expansion of its clinical service offerings. The company's strategic roadmap likely involves deepening its research capabilities and enhancing its patient engagement platforms to ensure long-term retention and improved health outcomes. As the firm moves forward, the focus will remain on solidifying its presence in the UK market while exploring potential international scalability. Investors are closely monitoring how this capital will be deployed to drive operational efficiency and establish Jude as a category-defining entity in the bladder health space.
See full Jude company page
